Rajendra Prasad Agrawal, Ashok Jhajharia, Niranjana Mohta, Rutba Dogra, Vineeta Chaudhari, Kailash Chandra Nayak
To improve outcomes for those with diabetic foot ulcers and, ultimately, to reduce the rate of lower-limb amputation, new treatment modalities are urgently needed. Platelet-derived growth factor may be an effective tool in the management of foot ulcers of diverse aetiologies. In this randomised control trial, participants with chronic diabetic foot ulcers who received platelet-derived growth factor therapy in addition to traditional wound care were found to be significantly more likely to progress to healing.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados